Navigation Links
BioInformatics, LLC, A Recognized Sponsor of First Annual Consumer Genetics Show in Boston, June 9-11, 2009
Date:2/9/2009

ARLINGTON, Va., Feb. 9 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com) -- the leading market research and consulting firm serving the life science industry -- will be a recognized sponsor of the First Annual Consumer Genetics Show (www.consumergeneticsshow.com) in Boston, MA at the Hynes Convention Center on June 9-11, 2009. BioInformatics, LLC will also be exhibiting at the show. The first conference of its kind, this event will showcase both genetic testing companies offering a wide variety of products, as well as the genetic tool companies that support this emerging healthcare specialty, a nascent market that is being watched closely by clients of BioInformatics, LLC.

"This field is largely uncharted," noted Tamara Zemlo, Ph.D. M.P.H, Vice President of Advisory Services for BioInformatics, LLC. "The implications of consumers ordering genetic testing -- without involving a physician -- are vast, and this conference is the first of its kind to bring together the biotech, healthcare, diagnostic and legal pioneers in the emerging field of 'personal genetics.'" Dr. Zemlo will present at the conference following keynote speaker Francis Collins, M.D., Ph.D., former Director of the National Human Genome Research Institute, who led the successful effort to complete the Human Genome Project.

Allowing the public access to the exhibit hall will give consumers an understanding of the various genetic tests and products on the market, as well as provide insight as to which of these tests may be most appropriate for their needs. Companies that provide the genetic tools, next generation sequencing platforms and SNP analysis instruments for these tests will also be present, thus allowing the consumer to gain an understanding of the fidelity of testing in these various personalized genetic services.

For an admission fee of $15 USD per person, professionals from the genetic research community and the public will be allowed access to the exhibit hall. Exhibitor and attendee registration forms can be found at http://www.consumergeneticsshow.com.

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our online panel of more than 40,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions.

    For more information contact:

    Mary Follin
    Manager, Marketing/Sales
    BioInformatics, LLC
    2111 Wilson Blvd., Suite 250
    Arlington, VA  22201
    703.778.3080 x13 (phone)
    m.follin@gene2drug.com

http://www.gene2drug.com


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
2. Health Advocate Recognized by Inc. 500 as One of the Nations Fastest Growing Private Companies
3. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
4. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
5. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
6. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
7. J.D. Power and Associates Reports: Rush-Copley Medical Center Recognized for Third Consecutive Year for Providing an Outstanding Inpatient Experience
8. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
9. Blue Cross and Blue Shield Association Nationally Recognized by BusinessWeek and AARP for Creating a Unique Workplace Environment for New and Mature Employees
10. Higher death rates in kidney patients with newly recognized disease
11. For Second Year Beryl Recognized as a Tech Titan, One of Texas Fastest- Growing Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 26, 2016 , ... OncLive® , a leading digital ... University of Virginia (UVA) Cancer Center to its quickly expanding ... teams will publicize and promote public awareness of UVA Cancer Center’s latest advances ...
(Date:5/26/2016)... ... May 26, 2016 , ... A health conscious snack that doesn't ... Bar, has ignited an undeniable buzz in the protein product community by offering ... any doughnut.  These doughnuts are packed with 11 grams of protein and made from ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... provide strategic sales leadership and to further develop their rapidly expanding portfolio of ... Business Administration with a concentration in Marketing and an M.B.A. with concentration in ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... enhance surgical safety efforts for several years, and the efforts have paid off. ... These efforts include new standards of care to enhance perioperative patient experiences and ...
(Date:5/26/2016)... ... 26, 2016 , ... Dr. LeRoy Perry’s recently authored whitepaper, “Tech Neck and ... the billions of users, hundreds of millions of whom are coming into the workplace ... frequent and common action of looking down at hand-held technology devices (tablets, smartphones) for ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... -- Cirujanos holandeses han puesto en marcha ... a compartir sus mejores prácticas por el mundo y ... de Europa, África, Asia y ... que combina la transmisión en vivo con mensajería instantánea ... Educación   "Imagine un médico de Medicines sans ...
(Date:5/24/2016)... Nev. , May 24, 2016  Diana Russell ... "eats" her organs from the inside out.  This disease ... completely dependent on her children and grandchildren to leave ... her wheelchair, Diana,s family cannot haul the wheelchair.  So ... in the car, and Diana is left to wait ...
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
Breaking Medicine Technology: